The bioprocess controllers and automation systems market is projected to be grow at an annualized growth rate of 10% by 2030, claims Roots Analysis
The bioprocess controllers and automation systems have
turned out to be a process optimization solution for the biopharmaceutical
industries, overcoming the inadequacies of the traditional bioreactor systems. Amidst
the COVID-19 pandemic, the increasing demand for biologics has led to the surge
in the adoption rate of the aforementioned systems. As a result, several
bioprocess equipment developers stepped up to offer more controlled and
automated systems in order to increase the productivity, shorten production
timelines, reduce cost of goods, and increase flexibility of the bioprocess.
To order this 230+ page
report, which features 105+ figures and 105+ tables, please visit https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html
Key Market Insights
120+ bioprocess
controllers and automation systems are being developed by various players in
this domain
Over 40% of the bioprocess
controllers and automation systems are being offered to optimize the downstream
processes, followed by over 30% controllers, which are used to optimize upstream
processes.
Over 25 companies claim to provide development services
related to bioprocess controllers and automation systems
The domain is featured by the presence of nearly 40% small players; of
which, over 30% of players are developing upstream controllers. Further, more than 50% of these players offering bioprocess controllers market and automation systems are based in Europe.
More than 3,500 patents have been filed / published related
to the bioprocess controllers and automation systems, as of July 2021
Close to 70% of these
were patent applications, while the remaining were granted patents. Of the
total patent applications, close to 65% were filed in North America, while
around 30% patents were filed in Europe.
Europe is anticipated
to capture over 42% of the market share by 2030
Bioprocess
controllers and automation systems developed for preclinical / clinical scale
operations currently capture the highest share (~75%) in the market; this trend
is unlikely to change in the foreseen future. Further, upstream / downstream
controllers hold the major share (~60%) in bioprocess controllers and
automation systems market.
To request a sample copy / brochure of this report, please
visit https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market/request-sample.html
Key
Questions Answered
§ Who are the leading players engaged in the development of
bioprocess controller and automation systems?
§ What are the different application areas where bioprocess
controller and automation systems can be used?
§ What are the key features of bioprocess controller and
automation systems?
§ How has the intellectual property landscape of bioprocess
controller and automation, evolved over the time?
§ What are the key trends within the bioprocess controllers
and automation systems market?
§ How is the current and future opportunity likely to be
distributed across key market segments?
By 2030, the financial opportunity within the bioprocess
controllers and automation systems market has been analyzed across the
following segments:
§ Type of Controllers
- Upstream / Downstream controller systems
- Bioprocess control software
§ Analysis by Scale of Operation
- Preclinical / Clinical Operation
- Commercial Operation
§ Analysis by Mode of Operation
§ Batch / Fed-batch
§ Perfusion
§ Analysis by Types of Systems
§ Single-use systems
§ Stainless Steel / Other Systems
§ Analysis by Geographical Regions
- North America
- Europe
- Asia Pacific and Rest of the World
The report also
features inputs from eminent industry stakeholders, according to whom, the several
bioprocessing companies are likely to adopt bioprocess controllers and
automation systems in the foreseen future. The report includes detailed
transcripts of discussion held with prominent industry representatives.
The research includes
profiles of key players (listed below); each profile features a tabulated
overview of company, product portfolio, recent developments, and an informed
future outlook.
§ Applikon Biotechnology
§ Cytiva
§ Repligen
§ Sartorius
§ Sepragen
§ Solaris Biotech
§ Sysbiotech
§ Thermo Fisher Scientific
For additional
details, please visit
https://www.rootsanalysis.com/reports/bioprocess-controllers-and-automation-systems-market.html or email sales@rootsanalysis.com
You may also be
interested in the following titles:
1.
Continuous
Manufacturing Equipment Providers Market: Industry Trends and Global
Forecast, 2021-2030
2.
Single-Use
Bioreactors Market (2nd Edition): Industry Trends and Global Forecast,
2021-2030
3.
Telemedicine
Tools and Software Providers Market: Industry Trends and Global
Forecasts, 2021-2030
4.
Cloud-based
Solutions for Drug Discovery, Development and Manufacturing Market: Industry Trends and Global
Forecast, 2021-2030
About Roots Analysis
Roots Analysis is one of the fastest growing market research
companies, sharing fresh and independent perspectives in the bio-pharmaceutical
industry. The in-depth research, analysis and insights are driven by an
experienced leadership team which has gained many years of significant
experience in this sector. If you’d like help with your growing business needs,
get in touch at info@rootsanalysis.com
Contact Information
Roots
Analysis Private Limited
Ben Johnson
+1 (415) 800 3415
Facebook - https://www.facebook.com/RootsAnalysis
LinkedIn - https://www.linkedin.com/company/roots-analysis/mycompany/
Twitter - https://twitter.com/RootsAnalysis
Medium - https://medium.com/@RootsAnalysis
Pinterest - https://in.pinterest.com/RootsanalysisPin/_saved/
Comments
Post a Comment